Why analysts are watching it
Analysts are watching JD due to observations about its market valuation and subsidiary holdings. On May 18, 2026, Couch Investor noted "JD 68.6" in his video "The Stocks Billionaire Investors Are Quietly Buying," an indicator drawing bearish sentiment. Conversely, on April 26, 2026, Sven Carlin, Ph.D., in his video "KWEB ETF - The Ugly Stocks Nobody Wants Cares About!", highlighted JD Health's significant market share in pharma e-commerce, while also pointing out competitive pressures from Alibaba. Carlin further suggested JD.com might be undervalued, stating, "It's much better to just own it through JD.com where it's practically not even priced in." This leads into his observation on April 27, 2026, from "Burry's Trades: Short TSLA, NVDA, long China, Fintech, Software", that JD holds a "7% position in JD". Investors should be aware that competition in the e-commerce and e-health sectors could impact future performance.
Contributing creators
Source clips
"JD Health which is 67% owned by JDcom that we discussed in the other video. 40% of the pharma e-commerce market but there is also competition. Alibaba's e- health"
— KWEB ETF - The Ugly Stocks Nobody Wants Cares About!
"Alibaba held still competition with JD held that we discussed."
— KWEB ETF - The Ugly Stocks Nobody Wants Cares About!
"It's much better to just own it through JD.com where it's practically not even priced in because what's that? At 20 billion US market cap, 67% of that, it's 12 billion JD's market cap is 50. So that's 25% of JD's market cap. It's not worth that much, which shows how cheap JD is."
— KWEB ETF - The Ugly Stocks Nobody Wants Cares About!
"7% position in JD"
— Burry's Trades: Short TSLA, NVDA, long China, Fintech, Software